Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Linvoseltamab (Lynozyfic TM) is approved by the FDA and EMA for adults with relapsed or refractory multiple myeloma after at least 4 prior lines of therapy (Proteasome inhibitor, IMiD (immunomodulatory agent), Anti-CD38 monoclonal antibody). It is not approved for plasmacytoma as a separate indication (1)
E…